A 2024 review describes the connection between GLP1 medications, delayed gastric emptying (including gastroparesis), and increased risk of aspiration during anesthesia, as well as possible effects on the absorption of other medications
Rinne P, Silvola JM, Hellberg S, et al
Detection of intracellular ROS ROS was measured using the fluorescent probe 2,7-dichlorofluorescin diacetate (DCFH-DA, Sigma), which can be hydrolyzed to DCFH within cells
How do I know if I am using a U-100 syringe
GLP-1 users are defined as patients with an approved claim for at least one of the following GLP-1 medications in the prior 12 months: Mounjaro, Ozempic, Rybelsus, Saxenda, Wegovy, and Zepbound